EGFR Expression in Bladder Cancer and Its Prognostic Factors
Author Information
Author(s): P. Lipponen, M. Eskelinen
Primary Institution: University of Kuopio
Hypothesis
The study investigates the relationship between epidermal growth factor receptor (EGFR) expression and various prognostic factors in bladder cancer.
Conclusion
Overexpression of EGFR is associated with several malignant features and poor prognosis in superficial bladder cancer.
Supporting Evidence
- EGFR was overexpressed in 35% of bladder cancer cases studied.
- Overexpression of EGFR was related to invasive growth and high proliferation rates.
- Progression of superficial tumors was significantly related to EGFR overexpression.
- Multivariate analysis indicated that EGFR overexpression is an independent predictor of tumor progression.
Takeaway
This study found that many bladder cancer patients have high levels of a protein called EGFR, which can make their cancer worse.
Methodology
The study involved immunohistochemical analysis of EGFR expression in bladder cancer tissues from 234 patients, followed by statistical analysis of survival and progression.
Potential Biases
Potential biases may arise from the selection of patients and the methods used for measuring EGFR expression.
Limitations
The study's findings may be influenced by the various treatments received by patients and the retrospective nature of the analysis.
Participant Demographics
The cohort consisted of 234 patients, with 193 males and 41 females, and a mean age of 67.2 years.
Statistical Information
P-Value
0.0268
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website